HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Walter Mier Selected Research

Experimental Liver Neoplasms

1/2007Polyamine-substituted gadolinium chelates: a new class of intracellular contrast agents for magnetic resonance imaging of tumors.
9/2006Angiopoietin-2 overexpression in morris hepatoma results in increased tumor perfusion and induction of critical angiogenesis-promoting genes.
9/2006Troponin I overexpression inhibits tumor growth, perfusion, and vascularization of morris hepatoma.
3/2006Angiostatin overexpression in Morris hepatoma results in decreased tumor growth but increased perfusion and vascularization.
10/2005Alkylating benzamides with melanoma cytotoxicity: role of melanin, tyrosinase, intracellular pH and DNA interaction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Walter Mier Research Topics

Disease

73Neoplasms (Cancer)
10/2022 - 08/2002
25Prostatic Neoplasms (Prostate Cancer)
01/2020 - 01/2005
9Infections
11/2020 - 03/2008
9Carcinoma (Carcinomatosis)
11/2018 - 03/2002
8Neoplasm Metastasis (Metastasis)
01/2021 - 10/2011
7Melanoma (Melanoma, Malignant)
07/2018 - 12/2002
7Hepatocellular Carcinoma (Hepatoma)
09/2014 - 10/2004
5Experimental Liver Neoplasms
01/2007 - 10/2005
4Neuroendocrine Tumors (Neuroendocrine Tumor)
05/2016 - 10/2008
3Pancreatic Neoplasms (Pancreatic Cancer)
10/2020 - 02/2016
3Inflammation (Inflammations)
01/2019 - 01/2002
3Squamous Cell Carcinoma of Head and Neck
11/2018 - 03/2009
3Pain (Aches)
01/2018 - 06/2012
3Hepatitis B
04/2014 - 03/2008
2Bacterial Infections (Bacterial Infection)
08/2021 - 07/2018
2Sepsis (Septicemia)
08/2021 - 01/2015
2Adenocarcinoma
01/2020 - 11/2005
2Xerostomia
06/2019 - 06/2017
2Liver Diseases (Liver Disease)
12/2018 - 04/2014
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2018 - 03/2009
2Breast Neoplasms (Breast Cancer)
01/2018 - 09/2005
2Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2016 - 03/2016
2Heart Failure
09/2014 - 05/2013
2Myocardial Infarction
05/2013 - 06/2005
2Head and Neck Neoplasms (Head and Neck Cancer)
03/2009 - 03/2002
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2008 - 08/2005
2Neuroblastoma
01/2008 - 06/2006
2Stroke (Strokes)
01/2008 - 08/2005
2Ischemia
01/2008 - 08/2005
2Infarction (Infarctions)
01/2008 - 08/2005
2Experimental Melanoma
10/2005 - 10/2004
2Astrocytoma (Pilocytic Astrocytoma)
04/2004 - 11/2002
1Septic Shock (Toxic Shock Syndrome)
08/2021
1Sarcoma (Soft Tissue Sarcoma)
01/2021

Drug/Important Bio-Agent (IBA)

33Peptides (Polypeptides)IBA
08/2021 - 08/2002
15LigandsIBA
01/2020 - 12/2002
14AntigensIBA
01/2020 - 02/2011
11Proteins (Proteins, Gene)FDA Link
10/2019 - 01/2004
9gallium 68 PSMA-11IBA
01/2019 - 01/2017
9Pharmaceutical PreparationsIBA
11/2018 - 02/2005
7Radioisotopes (Radionuclides)IBA
01/2019 - 05/2005
6Immunoconjugates (Immunoconjugate)IBA
10/2022 - 01/2013
61,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2019 - 02/2011
5RadiopharmaceuticalsIBA
10/2019 - 09/2005
468Ga-FAPIIBA
10/2019 - 01/2018
4benzamideIBA
07/2018 - 12/2002
4Melanins (Melanin)IBA
07/2018 - 10/2005
4N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA
08/2017 - 04/2012
4AlbuminsIBA
01/2017 - 01/2005
4PSMA-617IBA
08/2016 - 06/2015
4BenzamidesIBA
01/2014 - 12/2002
3Prostate-Specific Antigen (Semenogelase)IBA
01/2020 - 12/2017
3SFITGv6 peptideIBA
10/2019 - 08/2017
3IntegrinsIBA
10/2019 - 11/2018
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2019 - 03/2002
3Messenger RNA (mRNA)IBA
01/2017 - 12/2010
3Antineoplastic Agents (Antineoplastics)IBA
01/2017 - 01/2005
3Peptide Receptors (Peptide Receptor)IBA
05/2016 - 06/2007
3Urea (Carbamide)FDA LinkGeneric
01/2016 - 04/2012
3Somatostatin Receptors (Somatostatin Receptor)IBA
03/2015 - 08/2002
3Amino AcidsFDA Link
12/2010 - 04/2004
3Gadolinium DTPA (Magnevist)FDA Link
01/2007 - 11/2002
3Tyrosine (L-Tyrosine)FDA Link
04/2004 - 03/2002
2FAPI-46IBA
01/2021 - 10/2020
2Anti-Bacterial Agents (Antibiotics)IBA
11/2020 - 01/2020
2AntibodiesIBA
10/2020 - 11/2018
2CarbonIBA
01/2019 - 07/2018
2IonsIBA
01/2019 - 07/2018
2EpitopesIBA
01/2019 - 09/2014
2Biomarkers (Surrogate Marker)IBA
01/2019 - 03/2016
2Pyruvaldehyde (Methylglyoxal)IBA
01/2017 - 06/2012
2Cyclic PeptidesIBA
01/2017 - 05/2005
2Rituximab (Mabthera)FDA Link
10/2016 - 03/2016
2Protein Isoforms (Isoforms)IBA
02/2016 - 01/2004
2ranpirnase (Pannon)IBA
02/2015 - 01/2015
2Therapeutic UsesIBA
01/2015 - 05/2006
2Edotreotide (SMT 487)IBA
08/2014 - 10/2011
2Carbonic Anhydrase IXIBA
01/2012 - 12/2010
2CaspasesIBA
04/2010 - 01/2002
2DNA (Deoxyribonucleic Acid)IBA
09/2006 - 10/2005
2sodium-iodide symporter (sodium iodide symporter)IBA
05/2006 - 05/2006
2Monophenol Monooxygenase (Tyrosinase)IBA
10/2005 - 06/2004
2ElementsIBA
01/2004 - 12/2002
1EndotoxinsIBA
08/2021
1LipopolysaccharidesIBA
08/2021
11,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
08/2021
1SamariumIBA
01/2021
1VancomycinFDA LinkGeneric
01/2020
1GlycopeptidesIBA
01/2020
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2020
1CopperIBA
01/2020
1Chromogranin AIBA
01/2020

Therapy/Procedure

44Therapeutics
01/2021 - 03/2002
6Radiotherapy
01/2020 - 11/2002
5Castration
01/2020 - 07/2014
4Drug Therapy (Chemotherapy)
01/2018 - 02/2005
3Precision Medicine
10/2019 - 06/2015
3Radioimmunotherapy
10/2016 - 01/2013
2Gamma Cameras (Gamma Camera)
05/2006 - 05/2006
2Intraperitoneal Injections
05/2006 - 11/2005